LitCovid-sample-Enju  

PMC:7205724 / 263-570 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T37 7-8 PDT denotes •
T38 10-13 DT denotes The
T39 14-17 NN denotes use
T40 18-20 IN denotes of
T41 21-36 NNS denotes corticosteroids
T42 37-42 MD denotes might
T43 43-53 VB denotes accelerate
T44 54-62 NN denotes recovery
T45 63-67 IN denotes from
T46 68-76 NN denotes COVID-19
T47 78-79 PDT denotes •
T48 81-83 DT denotes No
T49 84-94 VBN denotes controlled
T50 95-103 JJ denotes clinical
T51 104-110 NNS denotes trials
T52 111-116 VBP denotes exist
T53 117-119 IN denotes on
T54 120-123 DT denotes the
T55 124-127 NN denotes use
T56 128-130 IN denotes of
T57 131-146 NNS denotes corticosteroids
T58 147-150 IN denotes for
T59 151-159 NN denotes COVID-19
T60 161-162 LS denotes •
T61 164-167 NN denotes IL6
T62 168-178 VBZ denotes correlates
T63 179-183 IN denotes with
T64 184-192 NN denotes severity
T65 192-193 -COMMA- denotes ,
T66 194-205 NN denotes criticality
T67 205-206 -COMMA- denotes ,
T68 207-212 JJ denotes viral
T69 213-217 NN denotes load
T70 217-218 -COMMA- denotes ,
T71 219-222 CC denotes and
T72 223-232 NN denotes prognosis
T73 233-235 IN denotes of
T74 236-244 NN denotes COVID-19
T75 246-247 IN denotes •
T76 249-260 NNP denotes Tocilizumab
T77 260-261 -COMMA- denotes ,
T78 262-264 DT denotes an
T79 265-273 NN denotes anti-IL6
T80 273-274 -COMMA- denotes ,
T81 275-278 MD denotes can
T82 279-285 VB denotes confer
T83 286-293 NN denotes benefit
T84 294-296 IN denotes in
T85 297-305 NNS denotes patients
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in